17 June 2020 – Dexamethasone usage on severe Covid-19 patients

Type of Intervention: Advisory
Sectors Involved: Health
Intervention Categories: Drug-based measures; Education and awareness
Level of Jurisdiction: National
Lead People/Agency: Health director-general

Overview: The Health director-general of Malaysia advised that dexamethasone should only be used on severe Covid-19 patients.
Full details here: https://www.thestar.com.my/news/nation/2020/06/17/health-dg-dexamethasone-should-only-be-used-on-severe-covid-19-patients

Type of Justification: Scientific Evidence (e.g. academic paper, report)
Evidence/Justification: Clinical trials have shown that dexamethasone is useful for Covid-19 advance cases, notably those in category four or five, but not for category one or two.